Solution for washing Red Blood Cells

AI Summary

NHS Blood and Transplant is opening a market engagement to explore commercial capabilities for a system that facilitates the routine washing and re‑suspension of red blood cells during the manufacture of specialist blood components. The objective is to identify, evaluate, and potentially procure equipment or processes that align with industry standards, specifically referencing platforms such as SAG‑M, PAGGSM, or AS3, which are commonly used for this purpose. By inviting suppliers to submit product literature, the procurement seeks to assess technical suitability, operational compatibility, and overall effectiveness in supporting the production workflow within the UK.

Potential suppliers are expected to demonstrate their solution’s ability to meet the rigorous requirements set out in the UK Blood Transfusion Services guidelines, including compliance with the Red Book specifications for washing and re‑suspension of red cells. No business or contractual award is guaranteed through this engagement, and all participants acknowledge that they bear responsibility for any costs incurred in the process. The solution must comply with UK Blood Transfusion Services guidelines and adhere to the Red Book standards.

Description

NHSBT wishes to engage with the market understand the markets capability to provide a solution (such as, but not limited to SAG-M, PAGGSM or AS3) for the routine washing and re-suspension of red cells during the production of specialist blood components in accordance with the Guidelines for the Blood Transfusion Services in the UK details of which can be found at the following website https://www.transfusionguidelines.org/red-book. Potential Suppliers should express their interest with a copy of any product literature to Samantha Rix at samantha.rix@nhsbt.nhs.uk by 30 April 2025 and Samantha will contact you to arrange an informal meeting. No business whatsoever is guaranteed under any resulting framework or contract, and there is no guarantee that any framework or contract will be put in place in relation to this notice. Each Potential Supplier is responsible for all costs and expenses incurred in relation to this Market Engagement exercise, each Potential Supplier accepts by its participation in this process, including without limitation the submission of any documents or attending meetings, that it will not be entitled to claim from NHSBT any costs, expenses or liabilities that it may incur irrespective of whether or not its tender is successful or if a tender or resulting framework or contract is withdrawn for any reason.

Estimated date of publication of contract notice: 2026-04-01T23:59:59+01:00
Contract location: UK
Engagement process description
NHSBT wishes to engage with the market understand the markets capability to provide a solution (such as, but not limited to SAG-M, PAGGSM or AS3) for the routine washing and re-suspension of red cells during the production of specialist blood components in accordance with the Guidelines for the Blood Transfusion Services in the UK details of which can be found at the following website https://www.transfusionguidelines.org/red-book. Potential Suppliers should express their interest with a copy of any product literature to Samantha Rix at samantha.rix@nhsbt.nhs.uk by 30 April 2025 and Samantha will contact you to arrange an informal meeting. No business whatsoever is guaranteed under any resulting framework or contract, and there is no guarantee that any framework or contract will be put in place in relation to this notice. Each Potential Supplier is responsible for all costs and expenses incurred in relation to this Market Engagement exercise, each Potential Supplier accepts by its participation in this process, including without limitation the submission of any documents or attending meetings, that it will not be entitled to claim from NHSBT any costs, expenses or liabilities that it may incur irrespective of whether or not its tender is successful or if a tender or resulting framework or contract is withdrawn for any reason.

Lot: 1
This contract is subject to renewal: Yes

Languages in which tenders or requests to participate may be submitted: En

Details

Status:
Forecast
Sectors:
33692000 - Medical solutions
33194220 - Blood-transfusion supplies
Place of origin:
United Kingdom of Great Britain and Northern Ireland
Places of performance:
United Kingdom of Great Britain and Northern Ireland
Deadline:
Nov 1, 2026, 12:00 AM
Contract duration:
Start date: 01 November 2026, End date: 31 October 2028
Contract type:
Member-only information
Publication date:
Member-only information
Created date:
Member-only information
Update date:
Member-only information

Stored documents

Member-only information

Original URL:

Member-only information
Contracting Entities
Member-only information